NEW YORK (GenomeWeb) – PathoQuest, announced today that it has partnered with Mayo Clinic to study the company's iDtect Blood test in order to improve the diagnosis of neutropenic fever in patients.  

As part of the collaboration, the Mayo Clinic will apply the next-generation sequencing-based metagenomic test in a prospective study designed to validate its utility.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.